Ask AI
ProCE Banner Activity

Integrating Bispecific Antibody Therapy for Multiple Myeloma Into Your Community Practice: Case Studies and Expert Guidance

Slideset

The downloadable slideset illustrates the principles needed to establish workflows that are required for community centers to fully integrate BsAb therapy into their patient care. Preparation and resources are needed to identify eligible patients and safely administer BsAb therapy. Education is necessary for healthcare professionals to understand how to manage the adverse effects possible with BsAbs, and pharmacies are required to establish a REMS program. 

Released: August 31, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity is intended for hematologists, oncologists, emergency medicine physicians, neurologists, infectious disease specialists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with multiple myeloma who are eligible for or receiving bispecific antibody therapy.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess each patient’s eligibility and potential barriers to receiving bispecific antibodies that are approved or under investigation in MM

  • Develop plans for coordinating care among different specialists, departments, and/or centers to optimize each patient’s therapeutic benefit from bispecific antibody therapy for MM

Additional Disclosures

Generative artificial intelligence (AI) tools were used for data analysis or summarization influencing content and revising or refining educational content  All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.